Related Experiment Video
Updated: Apr 9, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Menthol flavour enhancer use and willingness to buy under a menthol cigarette ban
Mayank Sakhuja1,2, Shayna Farris3, Marissa G Hall3,2,4
1Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA msakhuja@unc.edu.
Background:
In response to bans on menthol cigarettes, new products allow individuals to add menthol flavours to non-menthol cigarettes. Our study examined the past use of such products and willingness to use them in the future.
Methods:
We conducted an online survey in 2024 with a nationally representative sample of 1236 US adults (age 21+) who currently smoked menthol cigarettes. Participants reported ever using menthol flavour enhancers for cigarettes (filter tips, liquid, capsules or cards) and willingness to buy them if menthol cigarettes were banned.
Results:
Overall, 28% of participants had ever used menthol flavour enhancers. Past use was more common among those who used other tobacco products versus those who smoked only cigarettes (37% vs 11%, OR: 3.31, 95% CI 1.81 to 6.03). Past use was also higher among transgender adults, Western US residents, men, and participants in the combined racial category (Hispanic, multiracial or other) compared with non-Hispanic White participants (all p<0.05), while non-Hispanic Black participants did not differ (p>0.05). Overall, 55% of participants were willing to buy menthol flavour enhancers if menthol cigarettes were banned. The highest interest (29%) was in a menthol filter tip placed on cigarettes. Willingness was higher among participants who used other tobacco products and were transgender (both p<0.05).
Conclusions:
Interest in menthol enhancers was high among people who smoke menthol cigarettes, which could undermine the intended public health benefits of menthol cigarette bans. Policies to address menthol flavour enhancers, combined with surveillance and cessation support, may be important to the success of menthol bans.
More Related Videos
10:44Examination of Rapid Dopamine Dynamics with Fast Scan Cyclic Voltammetry During Intra-oral Tastant Administration in Awake Rats
Published on: August 12, 2015
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...